Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-873-0 | CAS number: 127-95-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
Effects of oxalic acid can only be expected at supra-physiological concentrations of oxalate, such as in case of chronic renal failure.
Additional information
The role of oxalic acid in renal failure and kidney stone formation is studied extensively, mostly by in vitro research, based on the presence of calcium oxalate monohydrate (COM) crystals in kidney stones. A summary of the publications provided in this dossier is presented below.
Study reference |
Study type |
Results |
Reliability |
NON KEY_1986_lit_Blumenfrucht |
Rat model of oxalosis after intravenous exposure (in vivo) |
Appearance of point source autoradiographs in heart, liver, lungs and in occasional glomerular capillaries suggest rapid formation of minute calcium oxalate crystals |
2 |
NON KEY_2005_lit_Guo |
Cytotoxicity of oxalate ions and calcium oxalate monohydrate (COM) crystals in human and rat proximal tubule cells (in vitro) |
Hemolysis of proximal tubule cells was caused by COM crystals, not by oxalate ions (in vitro). |
2 |
NON KEY_2004_lit_Knoll |
Effects of oxalate on distinct renal epithelial and endothelial cells as well as fibroblasts (in vitro) |
Sodium oxalate has a negative effect on the growth and survival of renal epithelial and endothelial cells and fibroblasts. |
2 |
NON KEY_2005_lit_Verkoelen |
Effect of oxalate ions as well as COM crystals on renal proximal and collecting tubule cells (in vitro) |
Oxalate ions were toxic only at superphysiological concentration, COM crystals are toxic to renal tubular cells only, which do normally not encounter crystals. |
2 |
NON KEY_2005_lit_Schepers |
Effect of oxalate to renal proximal and collecting tubule cells in culture (in vitro) |
Oxalate ions were toxic only at superphysiological concentration. |
2 |
NON KEY_1996_lit_Scheid |
Effects of oxalate exposure on production/availability of free radicals in renal proximal tubule cells (in vitro) |
Hyperoxaluria may contribute to the progression of renal injury in several forms of renal disease. |
2 |
NON KEY_1988_lit_Tonon |
Metabolic effects of oxalic acid in perfused liver compared to isolated liver cells |
Oxalate is less toxic for the intact liver than for isolated hepatocytes. |
2 |
Oxalic acid is toxic to renal cell lines in superphysiological concentrations only. The toxicity of calcium oxalate monohydrate crystals is higher. In vivo experiments show that after intravenous exposure to oxalate, precursors of these COM crystals may be formed. However, these effects seem to be dependent on exposure route. Furthermore, the experiment with perfused liver shows that the effect observed in in vitro studies occur at lower concentrations, and are therefore overestimating the toxicity of oxalic acid. In conclusion, effects of oxalic acid can only be expected at supra-physiological concentrations of oxalate, such as in case of chronic renal failure.
In assessing the hazard of oxalic acid, it should be kept in mind that oxalic acid is a natural substance which is present in various food substances, and in this way is consumed by the general population daily. From Gold et al (2001), the following table was derived, in which the average daily consumption of oxalic acid containing food is summarized. A total average daily consumption of 68.4 mg oxalic acid can be calculated from this table.
Food substance (average daily consumption) |
Average daily oxalic acid consumption |
Coffee (500 mL) |
25.2 mg |
Carrot (boiled, 12.1 g) |
22.7 mg |
Tea (60.2 mL) |
6.67 mg |
Chocolate (cocoa solids, 3.34 g) |
3.91 mg |
Tomato (88.7 g) |
3.24 mg |
Celery (7.95 g) |
1.39 mg |
Potato (54.9 g) |
1.26 mg |
Corn (33.8 g) |
1.12 mg |
Apple (32.0 g) |
704 µg |
(10.5 g) |
651 µg |
Lettuce (14.9 g) |
447 µg |
Broccoli (6.71 g) |
268 µg |
Strawberry (4.38 g) |
261 µg |
Cabbage (boiled, 12.9 g) |
155 µg |
Grapes (11 g) |
138 µg |
Cucumber (raw flesh, 11.8 g) |
118 µg |
Peach (canned, 9.58 g) |
115 µg |
Onions (green, cooked, 137 mg) |
31.5 µg |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.